Oncology & Cancer

New stem cell therapy to improve fight against leukemia

Stem cell transplantation is effective against leukemia. In many cases, however, the transferred immune cells of the donor also attack the recipients' healthy tissue—often with fatal consequences. Researchers at the University ...

Medical research

Helpful, hopeful news for bone marrow transplant patients

Leukemia can be a terrifying diagnosis for the more than 60,000 U.S. patients who are told they have this blood cancer every year. But the treatment for this disease can be just as frightening. For patients with certain forms ...

Surgery

New strategies for donor kidney preservation

New treatment strategies over the last few decades have meant that nowadays 95 percent of transplanted kidneys function well for at least one year and that the average lifespan of a transplanted organ is between 10 and 15 ...

Medical research

Engineered bone marrow could make transplants safer

Engineers at the University of California San Diego have developed biomimetic bone tissues that could one day provide new bone marrow for patients needing transplants.

Medical research

Donor epstein-barr serostatus influences GVHD after allo-HSCT

(HealthDay)—Donor Epstein-Barr virus (EBV) serostatus influences incidence of graft-versus-host disease (GVHD) in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation (allo-HSCT), according ...

page 2 from 6